抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Timigutuzumab
All
TD-HY286056_1.jpg
TD-HY286056_2.jpg
- Catalog： TD-HY286056
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： Trastuzumab,GEXMab73,GT-MAb7.3-GEX,TrastuzuMab-GEX,CAS:1665274-14-5
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Timigutuzumab
| Catalog No. | TD-HY286056 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | p185erbB2, HER2, NGL, Tyrosine kinase-type cell surface receptor HER2, NEU, MLN 19, Proto-oncogene Neu, MLN19, ERBB2, Proto-oncogene c-ErbB-2, CD340, Receptor tyrosine-protein kinase erbB-2, Metastatic lymph node gene 19 protein |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P04626 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | Trastuzumab,GEXMab73,GT-MAb7.3-GEX,TrastuzuMab-GEX,CAS:1665274-14-5 |
| Background | Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
Flow-cytometry using anti-human CD340 antibody. SK-BR-3 cells were stained with an irrelevant antibody (Blue Histogram) or an anti-human CD340 monoclonal antibody (Catalog TD-HY286056, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (TD-HF690414) and cells analysed on a NovoCyte Flow Cytometer. |
|
|
SDS-PAGE for Research Grade Timigutuzumab. |